FidoCure^® Veterinary Team Blog

As veterinarians, our work involves a wide range of emotions. We may experience the joy of treating a sick pet and seeing them recover, but we may also have to deliver the devastating news of a cancer diagnosis. It can be difficult to break such news to pet  parents who have a strong emotional bond with their dogs. However, as veterinary healthcare providers, it is our responsibility to help our clients through these tough times.

Canine cancer diagnoses can be devastating and demoralizing. While research and studies for human cancer have brought us a long way when it comes to treatment and instilling hope for our loved ones, the same can’t necessarily be said for the world of pet medicine. Despite this, there are many passionate veterinarians and vet oncologists out there who are helping to move the needle on pet cancer research and treatment. Taking cues from the progress made on human cancer treatment, FidoCure uses genomic testing to match dogs with targeted therapies for their specific cancer profile. Not only does this process increase the chances of a better prognosis, but it helps vets and vet oncologists deduce effective therapies for future canine cancer cases. FidoCure has already proven that a prognosis can be improved using targeted therapies. Take hemangiosarcoma for instance…